3
Clinical Trials associated with Umbilical cord derived mesenchymal stromal cells(Rohto Pharmaceutical Co Ltd)Intraovarian Allotransplantation of umbilical cord-derived mesenchymal stromal cells (UC-MSCs) in Patients with Premature Ovarian Insufficiency (POI) : clinical trial Phase II/I
An Exploratory Study to Investigate the Safety and Efficacy of UC-MSCs in Pediatric Patients With Cerebral Palsy
UDI-001 is administered to pediatric patients with cerebral palsy attributed to periventricular leukomalacia (PVL) multiple times to investigate its safety and efficacy.
Optimization of the Complex Treatment of Nonischemic Dilated Cardiomyopathy Due to the Addition to the Standard Drug Therapy of Intracoronary Administration of Umbilical Cord-derived Mesenchymal Stromal Cells
The purpose of this study is to optimize the complex treatment of chronic heart failure of non-ischemic etiology by supplementing umbilical cord mesenchymal stem cells to the standard drug therapy.
Start Date01 Mar 2020 |
Sponsor / Collaborator- |
100 Clinical Results associated with Umbilical cord derived mesenchymal stromal cells(Rohto Pharmaceutical Co Ltd)
100 Translational Medicine associated with Umbilical cord derived mesenchymal stromal cells(Rohto Pharmaceutical Co Ltd)
100 Patents (Medical) associated with Umbilical cord derived mesenchymal stromal cells(Rohto Pharmaceutical Co Ltd)
100 Deals associated with Umbilical cord derived mesenchymal stromal cells(Rohto Pharmaceutical Co Ltd)